Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60

Vaccine
A R Falsey, E E Walsh

Abstract

The safety and immunogenicity of purified fusion protein (PFP-2) respiratory syncytial virus (RSV) vaccine was evaluated in a randomized placebo-controlled, double-blind study of 64 healthy adults over age 60. Vaccination was well tolerated with no significant acute side-effects. Twenty-nine of 33 vaccinees (87%) showed a greater than or equal to fourfold rise in serum IgG to the F protein of RSV at 8 weeks post vaccination. Twenty of 33 vaccine recipients (61%) had a greater than or equal to fourfold rise in serum neutralizing titer to group A and/or group B RSV. Response to vaccination was inversely correlated with pre-immunization serum neutralizing titers. Active surveillance throughout the ensuring winter identified three RSV infections in the placebo group and none in the vaccine group. Thus, PFP-2 was found to be safe and immunogenic in healthy older adults.

References

Jan 1, 1992·Journal of Medical Virology·A R Falsey, E E Walsh
Apr 1, 1991·The Journal of Infectious Diseases·C B HallK C Schnabel
Nov 1, 1987·Reviews of Infectious Diseases·R L Saltzman, P K Peterson
Sep 1, 1987·The American Review of Respiratory Disease·T VikerforsP Olcen
Oct 22, 1973·JAMA : the Journal of the American Medical Association·R P WenzelJ M Gwaltney
Nov 1, 1984·The Journal of Infection·F J SorvilloS L Fannin
Nov 8, 1980·British Medical Journal·D G Garvie, J Gray
Aug 1, 1995·The Journal of Infectious Diseases·A R FalseyR F Betts
Sep 1, 1994·The Pediatric Infectious Disease Journal·P R ParadisoD H Smith

❮ Previous
Next ❯

Citations

Dec 1, 1999·Reviews in Medical Virology·M Zambon
Feb 11, 2000·Antiviral Research·J Treanor, A Falsey
Apr 19, 2013·The Journal of Infectious Diseases·Jim E EylesManinder K Sidhu
May 29, 2004·Current Opinion in Infectious Diseases·Carol Beadling, Mark K Slifka
Jul 17, 1998·Clinical Microbiology Reviews·R A Dudas, R A Karron
Aug 2, 2002·The Pediatric Infectious Disease Journal·Pedro A Piedra
Jan 20, 2004·The Pediatric Infectious Disease Journal·Fernando P Polack, Ruth A Karron
Apr 23, 2008·Current Opinion in Pulmonary Medicine·Yoshihiko Murata
Jul 25, 2000·Clinical Microbiology Reviews·A R Falsey, E E Walsh
Oct 5, 2001·Clinical Microbiology Reviews·P H Dennehy
Apr 16, 2004·Clinical Microbiology Reviews·Andrew J EastonHelene F Rosenberg
Jul 26, 2005·Drugs & Aging·Ann R Falsey, Edward E Walsh
Dec 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anna P Durbin, Ruth A Karron
Nov 4, 2009·Expert Review of Anti-infective Therapy·Jessica LüsebrinkOliver Schildgen
Oct 28, 2015·Expert Review of Vaccines·Noushin JaberolansarMariusz Skwarczynski
Jul 16, 2005·Expert Opinion on Biological Therapy·Martin Cranage, Geraldine Taylor
Jun 4, 2004·Expert Opinion on Investigational Drugs·Wieslawa OlszewskaPeter J M Openshaw
Oct 13, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Ann R FalseyEdward E Walsh
Nov 7, 2009·Clinics in Laboratory Medicine·Yoshihiko Murata
Aug 28, 2007·Comparative Immunology, Microbiology and Infectious Diseases·Gilles MeyerFrançois Schelcher
Sep 26, 2006·Journal of Medical Virology·Ann R FalseyEdward E Walsh
Nov 5, 1999·The Journal of Pediatrics·C G Prober, W M Sullender
Sep 4, 2015·Vaccine·Jorge C G BlancoMarina S Boukhvalova
Jun 13, 2015·Current Opinion in Immunology·Barney S GrahamJason S McLellan
Jun 7, 2014·The Journal of Infectious Diseases·Helen Y ChuJanet A Englund
Jun 20, 2013·Seminars in Immunology·Larry J Anderson
Apr 9, 2015·Drugs & Aging·Angela R Branche, Ann R Falsey
Sep 15, 1999·Lancet·E A Simoes
Sep 10, 2002·The Journal of Infection·C L Collins, A J Pollard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.